MC

Analyst Note: Moelis & Company (MC) Date: 2026-06-13

1. Structural Readiness

Current State: Forming

• Current Price: $67.18
• Aggressive Entry (Pre-Breakout): $66.81
• Breakout Level (Resistance): $78.05
• Extension: None recorded.
• Volatility Context: Current ATR is 4.2% (High). This sits within the historical "sweet spot" (4–6%) for structural quality, suggesting sufficient momentum to drive a move if the breakout occurs, without the extreme volatility (>8%) associated with severe structural failure.

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Macro Context: There is no named secular thesis attached to this setup as of 2026-06-13. The investment case is not driven by a specific macro regime change or a named long-term thematic shift (e.g., "The AI Infrastructure Boom" or "The Green Energy Transition"). Judgment Criteria: The conviction must be derived strictly from the quality of the technical setup (the forming coil) and the immediate business fundamentals reported in the most recent earnings cycle. The setup is being judged on its own merits: the alignment of a strong business trajectory with a constructive price structure.

3. The Business

Company Profile: Moelis & Company operates as a leading global independent investment bank. It functions as a single business segment providing advisory services to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. Core Activities: The firm generates substantially all revenue through advisory services on mergers and acquisitions (M&A), recapitalizations, restructurings, capital markets transactions, private fundraisings, and secondary transactions. Revenue recognition occurs over time as performance obligations are fulfilled. Operational Scale (as of Feb 2026): The firm employs 1,416 people across over 20 offices, including 178 Managing Directors. Over the past five years, the firm added 95 Managing Directors to enhance sector and product capabilities. Recent Performance (Q1 2026):

• Revenue: Reported record first-quarter revenues of $320 million, a 4% increase year-over-year.
• Margins: Adjusted pretax margin improved to 15% in Q1 2026, up from 14% in the prior year period.
• Pipeline: Management reported a pipeline near all-time highs and record levels of announced transaction activity.
• Growth Drivers: M&A revenues from sponsors grew double digits. Management noted strong demand for growth capital from high-quality issuers, particularly in late-stage growth, pre-IPO issuance, and sectors like AI, digital infrastructure, and aerospace/defense. Additionally, the market for GP-led secondaries hit record levels, driven by demand for liquidity solutions.

4. Archetype and Conviction

Archetype: Quality Compounder Rationale: The name fits the "Quality Compounder" archetype based on the evidence of expanding margins (14% to 15%), record revenue growth, and a pipeline near all-time highs. The business model demonstrates the ability to scale earnings through a lean, high-margin advisory structure while expanding its talent base (MDs) to capture larger fee pools. Valuation Context: The financial spine indicates a forward consensus EPS of $3.09 for FY1 and $3.95 for FY2. This implies a market expectation of significant earnings growth (approx. 28% CAGR over the next two years based on consensus). Conviction Stack:

• Thesis Strength: Moderate (Tactical, no macro tailwind named).
• Evidence Quality: High. Recent earnings (April 2026) and filings (Feb 2026) provide concrete data on revenue, margins, and pipeline health.
• Structural Quality: High. The ATR of 4.2% suggests a healthy, active market environment for the stock.
• Rerating Potential: Dependent on the confirmation of the breakout above $78.05. The current price ($67.18) is below the breakout level, meaning the market has not yet priced in the full potential of the "all-time high" pipeline.

5. Invalidations, Strengths, and Gaps

Strengthening Factors:

Evidence Gaps:

• A close above $78.05 would confirm the breakout, transitioning the setup to "Confirmed-Active."
• Continued management commentary on record pipeline levels or margin expansion in subsequent quarters.
• Sustained double-digit growth in sponsor M&A revenues.
• Missing Evidence: There is no specific data on the *duration* of the current forming base (how many weeks/months it has been consolidating) in the provided evidence block.
• Missing Evidence: No specific data on the *size* of the breakout volume or the *depth* of the pullback relative to the prior swing is provided in the evidence block, though the ATR is noted.
• Missing Evidence: No specific guidance on *capex* or *hiring* targets for the remainder of 2026 beyond the historical addition of 95 MDs over five years.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Record Q1 2026 revenues of $320 million with 4% YoY growth; Adjusted pretax margin expansion to 15%; Pipeline near all-time highs with double-digit growth in sponsor M&A. Key risks: Breakout failure at $78.05 resistance; Potential macro slowdown in M&A activity reversing the current record pipeline; ATR volatility (4.2%) could lead to whipsaw if support at $61.93 is tested. Sizing hint: Position size should reflect the partial readiness of the forming coil; allocate based on the 69% historical breakout probability rather than a confirmed breakout. Expected path: Management expectations of a strong pipeline and margin expansion should drive price action toward the $78.05 breakout level; if cleared, the structure suggests a continuation of the trend. Expected horizon: 3 to 6 months for the forming coil to resolve into a confirmed breakout or invalidation.